Montana resident Kara Mae Pletan has filed a lawsuit against Humira manufacturer Abbot Laboratories, saying the drug caused permanent nerve damage in her feet. The lawsuit also states that Abbot knew about the side effects before it began marketing the drug to Crohn’s patients in 2007.
Pletan filed the lawsuit in a Chicago state court near where the company’s headquarters is located, after two doctors at the Mayo Clinic said her nerve damaged was most likely due to Humira. The lawsuit states that Pletan developed small fiber peripheral neuropathy in 2008 , after three months of injections and that the progression of the damaged stopped after discontinuing Humira injections.
Initially sold as a treatment for rheumatoid arthritis, Humira has been approved by the FDA as a treatment of five autoimmune diseases, including Crohn’s disease. In early 2006 a report issued by Angers University in France suggested that a potential side effect of Humira was peripheral neuropathy. Pletan said that Abbot was aware of these finding before its use as a Crohn’s treatment.
Pletan’s lawsuit says that the nerve damage seems permanent and that she is seeking economic and punitive damages.